1/74
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
___________ irreversibly acetylates COX enzymes
Aspirin
Lifetime of a platelet?
7-10 days
______________:
Inhibits TXA2 for the life of platelet (7-10 days) (COX-1)
Inhibits PGI2 partially in the epithelium (COX-2)
Aspirin
Aspirin is _______________ (selective/non-selective)?
Nonselective
(**Acetylates both COX1 and COX2)
COX 2 inhibitors block __________ and **NOT TXA2
PGI2
______________:
- ASA – 7-10 days
- Ibuprofen, Diflunisal – 24 hrs
- Naproxen, Diclofenac, Indomethacin (48 hrs)
- Piroxicam – 72 hrs
- ***Reversible inhibitors - very little platelet inhibitory activity
NSAIDs
NSAIDs: time
- ASA – ______________
7-10 days
NSAIDs: time
- Ibuprofen, Diflunisal – ________
24 hrs
NSAIDs: time
- Naproxen, Diclofenac, Indomethacin – ________
48 hrs
NSAIDs: time
- Piroxicam – ________
72 hrs
NSAIDs: ____________ inhibitors - very little platelet inhibitory activity
Reversible
_________ side effect:
GI
- Dyspepsia
- GERD
- PUD
Bleeding – GI
- **Bruising up to 40% of patients
NSAIDs
________________________: Inhibit ADP binding to platelet receptors
-- P2Y1 receptor – pathway induces shape change and aggregation
-- P2Y12 receptor – inhibits cAMP-induced inhibition of platelet activation
Antiplatelet Agents: ADP Receptor Blockers
- Clopidogrel (Plavix®)
- Ticagrelor (Brilinta)
- Prasugrel (Effient)
(**-grel)
______________________: Activation of both receptors types needed for complete platelet activation, blocking of just one limits platelet activation
Antiplatelet Agents: ADP Receptor Blockers
- Clopidogrel (Plavix®)
- Ticagrelor (Brilinta)
- Prasugrel (Effient)
(**-grel)
ADP Receptor Blockers
Direct inhibition of fibrinogen binding to GPIIb/IIIa
Antiplatelet Agents: ADP Receptor Blockers
- Clopidogrel (Plavix®)
- Ticagrelor (Brilinta)
- Prasugrel (Effient)
(**-grel)
_______________________: Interferes with binding of Von Willebrand factor
Antiplatelet Agents: ADP Receptor Blockers
- Clopidogrel (Plavix®)
- Ticagrelor (Brilinta)
- Prasugrel (Effient)
(**-grel)
_________________________:
- Clopidogrel (Plavix®)
- Ticagrelor (Brilinta)
- Prasugrel (Effient)
Antiplatelet Agents: ADP Receptor Blockers
- Clopidogrel (Plavix®)
- Ticagrelor (Brilinta)
- Prasugrel (Effient)
(**-grel)
Antiplatelet Agents: ADP Receptor Blockers are _____________________ inhibition of platelet activation***
- Clopidogrel (Plavix®)
- Ticagrelor (Brilinta)
- Prasugrel (Effient)
(**-grel)
concentration dependent
______________________: are delayed 2-3 days for clinical effect MAX effect 8-11 days!!
Antiplatelet Agents: ADP Receptor Blockers
- Clopidogrel (Plavix®)
- Ticagrelor (Brilinta)
- Prasugrel (Effient)
(**-grel)
What class of drugs are synergistic with ASA?
Antiplatelet Agents: ADP Receptor Blockers
- Clopidogrel (Plavix®)
- Ticagrelor (Brilinta)
- Prasugrel (Effient)
(**-grel)
______________: prevent STROKE, MI, peripheral artery disease, angioplasty
Antiplatelet Agents: ADP Receptor Blockers
- Clopidogrel (Plavix®)
- Ticagrelor (Brilinta)
- Prasugrel (Effient)
(**-grel)
______________________: Prodrug
- Binds sulfur on P2Y12 receptor, synergistic with aspirin
Adverse effects:
***Thrombotic Thrombocytopenic Purpura (TTP)
Antiplatelet Agents: ADP Receptor Blockers
Clopidogrel (Plavix®)
______________: Prodrug
- Binds P2Y12 receptor, synergistic with aspirin
- Recommended over clopidogrel due to more platelet inhibition
Adverse effects
- Hypertension 8%
Antiplatelet Agents: ADP Receptor Blockers
Prasugrel (Effient®)
____________________:
- Not a prodrug, but has active metabolite
- Binds P2Y12 receptor, synergistic with aspirin
- Recommended over clopidogrel due to more platelet inhibition
Increased uric acid 22% (bad 4 GOUT)
Antiplatelet Agents: ADP Receptor Blockers
Ticagrelor (Brilinta®)
__________________ infusions (T1/2 30 min)
- Humanized monoclonal antibody
- Immediate onset, stays bound 18-24 hrs after infusion stopped, expensive
- Angioplasty with ASA and heparin, prevent restenosis
Adverse effects:
****Anaphylactic Rxn:
-- Could develop Neutralizing Abs
Antiplatelet Agents: Glycoprotein IIb/IIIA Blockers
Abciximab (ReoPro®)
____________________: inhibits the final pathway for platelet aggregation.
- Good for UA/NSTEMI, pt's undergoing PCI.
C/I: internal bleeding w/in30 days; major trauma/surgery, thrombocytopenia.
Antiplatelet Agents: Glycoprotein IIb/IIIA Blockers
- Tirofiban (Aggrastat®)
- Eptifibatide (Integrilin®)
- Abciximab (ReoPro®)
"TEA with IIb/III"
_______________________ infusions
- Peptide inhibitor of fibrinogen binding to PGIIb/IIIa, infusions up to 96 hrs
- Infusion, with ASA and heparin
- Acute coronary events and angioplasty
Adverse effects:
- Bleeding (10-12%)
- Bradycardia
- Dizziness
Antiplatelet Agents: Glycoprotein IIb/IIIA Blockers
Eptifibatide (Integrilin®)
___________________ infusions
- Non-peptide inhibitor, renal elimination
- Infusion, used with heparin
Adverse effects:
- Bradycardia
***LEAST Abs RXN!
Antiplatelet Agents: Glycoprotein IIb/IIIA Blockers
Tirofiban (Aggrastat®)
3 Antiplatelet Agent in order of least hypersensitivity --> worst
Tirofiban < Eptifibatide < Abciximab
______________: Antithrombin III suicide substrate of activated factors IIa >Xa >IXa >XIa >XIIa
Anticoagulants: Heparin
____________ provides platform for binding of thrombin to antithrombin.
Anticoagulants: Heparin
______________: Binds to & boosts/potentiates Antithrombin III's ability to inactivate Factor Xa, inactivates Thrombin (Factor IIa), inhibiting fibrin formation. Prevents new clot formation (however, does not dissolve existing clots!!!)
- Intrinsic pathway and Compliment pathway = Heparin (blocks II and X, IX, XI, XII)
Anticoagulants: Unfractionated Heparin (UFH)
____________: Extracted from porcine intestinal mucosa or bovine lung
(**Immunogenicity is higher from animals!)
Anticoagulants: Unfractionated Heparin (UFH)
______________: ***DOES NOT cross Placenta or BBB, not in breast milk, plasma protein bound.
(** It's too large to cross to fetus/breastfeeding infant!)
Anticoagulants: Unfractionated Heparin (UFH)
________________: Dose dependent t1/2, may ↑ in cirrhosis and renal failure
- IV or SQ only (***CANNOT be given orally, stomach will break down)
- ***aPTT monitoring test!
Anticoagulants: Unfractionated Heparin (UFH)
What test monitors Heparin?
aPTT
Monitoring parameters of ____________
aPTT (activated Partial Thromboplastin Time)
(aPTT ratio = patients aPTT / normal aPTT control)
Anticoagulants: Unfractionated Heparin (UFH)
_____________: Reversed by ***Protamine Sulfate (binds)
Anticoagulants: Unfractionated Heparin (UFH)
TOXICITY:
Anticoagulants: Unfractionated Heparin (UFH) can be reversed with _____________
Protamine Sulfate
Heparin-Induced Thrombocytopenia (HIT) is a toxicity expected with _______________.
Anticoagulants: Unfractionated Heparin (UFH)
If you see the following toxicity rxns, think _________________.
- Major Bleeding (reversed w/protamine sulfate)
- Heparin-Induced Thrombocytopenia (HIT)
Anticoagulants: Unfractionated Heparin (UFH)
_______________________: binds to & boosts/potentiates antithrombin III's ability to inactivate Factor Xa.
- Given SubQ as fixed or weight-adjusted dose once or twice daily
Chopped up Unfractionated Heparin (UFH) [Anticoagulants]
- Enoxaparin (Lovenox®)
- Dalteparin
Anticoagulants: Low Molecular Weight Heparin
(**-parin)
Do you use an aPTT test to monitor Low Molecular Weight Heparin?
No.
(**Heavier activity on X, less on II. IX, XI, XII = no aPTT.)
What test do you use to monitor Enoxaparin (Lovenox®) [AKA: Low Molecular Weight Heparin]?
A. aPTT
B. Anti-factor Xa assay
Anti-factor Xa assay
If a pt had a ****Heparin-Induced Thrombocytopenia (HIT) rxn to Unfractionated Heparin (UFH), what other drug should they AVOID?
Anticoagulants: Low Molecular Weight Heparin
(**-parin)
Which anticoagulant has the least risk for developing **Heparin-Induced Thrombocytopenia (HIT)?
Anticoagulant: Fondaparinux (Arixtra)
_______________ is a synthetic pentasaccharide based on antithrombin binding region of heparin.
- SubQ once daily, t1/2 17-21 hrs
- Not used in renal failure
- Low incidence of HIT
- Knee, hip replacement, pulmonary embolism, venous thrombosis
Anticoagulant: Fondaparinux (Arixtra)
_____________: Direct ***Factor Xa inhibitor (binds to & enhances antithrombin).
(**NO DIRECT EFFECT ON THROMBIN!)
Anticoagulant: Fondaparinux (Arixtra)
________________: Based on Hirudin, natural product from salivary glands of medicinal leech inhibit thrombin directly.
(****JUST WORKs ON FACTOR II - THROMBIN)
Anticoagulants: Direct Thrombin Inhibitors
________________: Based on Hirudin, natural product from salivary glands of medicinal leech inhibit thrombin directly.
- Lepirudin (Refludan®)
- Bivalirudin (Angiomax®)
- Argatroban (Acova®)
Anticoagulants: Direct Thrombin Inhibitors
(**-rudin, Argatroban)
What direct thrombin inhibitor is used in Heparin-Induced Thrombocytopenia (HIT), aPTT 1.5-2.5 X normal, IV, **renal excretion
Anticoagulants: Direct Thrombin Inhibitors
Lepirudin (Refludan®)
What direct thrombin inhibitor coronary angioplasty, IV, renal excretion?
Anticoagulants: Direct Thrombin Inhibitors
Bivalirudin (Angiomax®)
What direct thrombin inhibitor is used in Heparin-Induced Thrombocytopenia (HIT), aPTT 1.5-3 X normal, **hepatic excretion?
Anticoagulants: Direct Thrombin Inhibitors
Argatroban (Acova®)
What is special about Warfarin (Wisconsin Alumni Research Foundation) that other anticoags aren't?
(**-coum)
It is orally bioavailable!
______________ is more potent and it is metabolized by CYP2C9.
A. S-warfarin
B. R-warfarin
S-warfarin
Which anticoagulant is a Vitamin K antagonist?
Anticoagulants: Warfarin (Coumadin)
_____________ doesn't kick in immediately.
- It inhibits Vitamin K epoxide reductase rxn and ***prevents NEW clotting factors, but doesn't get rid of already made factors.
Anticoagulants: Warfarin (Coumadin)
_____________ has a ***DELAYED ONSET, but is great for long-term anticoagulant therapy.
Anticoagulants: Warfarin (Coumadin)
____________________: Initial hyper-coagulable state for first 24 -48 hrs d/t depletion of protein C.
- ****Cover with HEPARIN in high risk patients
Anticoagulants: Warfarin (Coumadin)
___________________:
- Given orally; 100% absorption
- T1/2 ~ 36 hours: steady state in 3-5 days
- Highly protein-bound (99%) to albumin
- Metabolized in LIVER
- S- warfarin CYP2C9
- R-warfarin CYP1A2 and 3A4
- Crosses placenta – C/I pregnancy***
- Not present in breast milk
Anticoagulants: Warfarin (Coumadin)
Warfarin is contraindicated in ____________ (fat soluble vitamins are needed by fetus)
pregnancy
What dietary guidance do pt's on Warfarin need?
They need a constant intake of Vitamin K
Things that affect pt's on ___________
1) Uptake and metabolism of oral drugs or vitamin K (green leafy vegetables)
2) Synthesis, function, or clearance of clotting factors
Anticoagulants: Warfarin (Coumadin)
Important source of Vitamin K?
gut bacteria
What two tests should you order for patients on Anticoagulants: Warfarin (Coumadin)?
PT & INR
What INR value are you shooting for in pt's with Warfarin?
2-3.5
(**Normal = 1)
___________________ sensitivity can be present in pt's with CYP2C9 alleles (much less efficient metabolism).
Anticoagulants: Warfarin (Coumadin)
Serious bleeding at any INR: GIVE these (2) things __________ + _____________.
Fresh Frozen Plasma (FFP) + Vitamin K
(**FFP has clotting factors. Gives them right back to pt...)
Pt was given too much Warfarin. When do you give Vitamin K1 (Phytonadione) PO, IV, or SubQ (AquaMEPHYTON, Mephyton, Konakion)?
INR > 5
***OTC Supplements that start with the letter G (eg, ginkgo biloba) + pt's on Anticoagulants: Warfarin (Coumadin) = ________________
Cranial Hemorrhage
Alternatives to ______________:
- Dabigatran etexilate (Pradaxa®)
- Rivaroxaban (Xarelto®)
- Apixaban (Eliquis®)
Anticoagulants: Warfarin (Coumadin)
______________: Prevents fibrinogen --> Fibrin, activation of factors V, VIII, XI, and XIII
Uses: DVT, PE, A-fib
- NO ROUTINE MONITORING NEEDED
- Alternative to Anticoagulants: Warfarin (Coumadin)
Anticoagulants: Dabigatran Etexilate (Pradaxa®)
What do you use to reverse Dabigatran Etexilate (Pradaxa®)?
Anticoagulants: Idarucizumab (Praxbind)
_________________: Oral factor Xa inhibitor
Reversible: Can be reversed with prothrombin complex concentrate (PCC)
Uses: DVT, atrial fibrillation, PE
- Alternative to Anticoagulants: Warfarin (Coumadin)
Anticoagulants: Rivaroxaban (Xarelto)
________________: Oral Factor Xa inhibitor
No routine monitoring needed
- Alternative to Anticoagulants: Warfarin (Coumadin)
Adverse Effects:
Metabolized by CYP3A4 (major)
Anticoagulants: Apixaban (Eliquis)